# Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori

> **NCT00712413** · PHASE3 · WITHDRAWN · sponsor: **Forest Laboratories**

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** OBMT

## Key facts

- **NCT ID:** NCT00712413
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-08
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712413, "Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00712413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*